[HTML][HTML] MicroRNAs as important contributors in the pathogenesis of colorectal cancer

S Ghafouri-Fard, BM Hussen, E Badrlou, A Abak… - Biomedicine & …, 2021 - Elsevier
Colorectal cancer (CRC) is the third most fatal and fourth most frequently diagnosed
neoplasm in the world. Numerous non-coding RNAs have been shown to contribute in the …

[HTML][HTML] Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy

S Wei, W Hu, J Feng, Y Geng - Cell Communication and Signaling, 2022 - Springer
Abstract Anti-epidermal-growth-factor-receptor (EGFR) monoclonal antibodies (mAbs) are of
great significance for RAS and BRAF wild-type metastatic colorectal cancer (mCRC) …

[HTML][HTML] Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer

H Shaath, SM Toor, MA Nada, E Elkord, NM Alajez - Scientific Reports, 2021 - nature.com
Colorectal cancer (CRC) remains a global disease burden and a leading cause of cancer
related deaths worldwide. The identification of aberrantly expressed messenger RNA …

[HTML][HTML] SCAT8/miR-125b-5p axis triggers malignant progression of nasopharyngeal carcinoma through SCARB1

C Jiang, D Feng, Y Zhang, K Yang, X Hu… - BMC Molecular and Cell …, 2023 - Springer
Nasopharyngeal carcinoma is a tumor with high malignancy and poor prognosis, which
severely affects the health of the patients. LncRNAs and microRNAs are crucial for the …

Prognostic value of BRAF/MIR‐17 signature and B‐Raf protein expression in patients with colorectal cancer: A pilot study

AT Ibrahiem, MS Fawzy, BT Abu AlSel… - Journal of clinical …, 2021 - Wiley Online Library
Background Despite the recent improvement in colorectal cancer (CRC) treatment, it still has
a poor prognosis with a low survival rate. Genetic and epigenetic mechanisms have proved …

[HTML][HTML] KRAS Promoter Methylation Status and miR-18a-3p and miR-143 Expression in Patients With Wild-type KRAS Gene in Colorectal Cancer

JA Herrera-Pulido, OR Guerrero, JA Forero… - Cancer Diagnosis & …, 2022 - ncbi.nlm.nih.gov
Background/Aim: Although some mutations of KRAS proto-oncogene, GTPase (KRAS) have
been associated with the prognosis and therapeutic management of colorectal cancer …

[HTML][HTML] KRAS Promoter Methylation Status and miR-18a-3p and miR-143 Expression in Patients With Wild-type KRAS Gene in Colorectal Cancer

HPJ ALIRIO, GO RICAURTE, FJ ACOSTA, MA PABLO… - cancerdiagnosisprognosis.org
Background/Aim: Although some mutations of KRAS proto-oncogene, GTPase (KRAS) have
been associated with the prognosis and therapeutic management of colorectal cancer …

DESREGULAÇÃO DE microRNAs EM PROCESSOS PATOLÓGICOS DO CÂNCER

MDM Padilha, RNM Feitosa - RECIMA21-Revista Científica …, 2022 - recima21.com.br
Resumo miRNAs são moléculas endógenas de 19 a 25 nucleotídeos, essas moléculas são
transcritas pela RNA polimerase II, após a transcrição, os microRNAs são processados por …